Literature DB >> 8546726

Healing phenomena of erosive changes in rheumatoid arthritis patients undergoing disease-modifying antirheumatic drug therapy.

R Rau1, G Herborn.   

Abstract

OBJECTIVE: To describe radiographic healing phenomena and reparative changes of joint destruction in rheumatoid arthritis (RA).
METHODS: Serial radiographs of 6 patients with erosive RA undergoing long-term treatment with disease-modifying antirheumatic drugs (DMARDs) were studied. Radiographs showing healing phenomena were reproduced, and examples of single joints are shown.
RESULTS: The examples show recortication of erosions, filling in of erosions with new bone, and secondary osteoarthrosis with bone sclerosis and osteophyte formation. Commonly use radiographic scoring methods do not have the capacity to account for these reparative changes.
CONCLUSION: Healing phenomena can be observed in RA patients undergoing long-term DMARD treatment. These phenomena can be regarded as clinical end points, and their assessment should be incorporated into existing standardized methods for radiologic evaluation and scoring of RA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8546726     DOI: 10.1002/art.1780390123

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

Review 1.  [Imaging techniques in rheumatology: conventional radiography in rheumatoid arthritis].

Authors:  R Rau; G Lingg; S Wassenberg; C Schorn; A Scherer
Journal:  Z Rheumatol       Date:  2005-10       Impact factor: 1.372

2.  HLA-B27 modulates the survival of Salmonella enteritidis in transfected L cells, possibly by impaired nitric oxide production.

Authors:  M Virtala; J Kirveskari; K Granfors
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

3.  Expansion of a unique macrophage subset in rheumatoid arthritis synovial lining layer.

Authors:  M Tanaka; T Nagai; Y Tsuneyoshi; N Sunahara; T Matsuda; T Nakamura; S Tsuyama; K Hasui; O FitzGerald; T Matsuyama
Journal:  Clin Exp Immunol       Date:  2008-08-22       Impact factor: 4.330

4.  What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x rays and magnetic resonance imaging over the first two years of disease.

Authors:  F M McQueen; N Benton; J Crabbe; E Robinson; S Yeoman; L McLean; N Stewart
Journal:  Ann Rheum Dis       Date:  2001-09       Impact factor: 19.103

5.  Magnetic resonance imaging of the wrist in rheumatoid arthritis: demonstration of progression between 1 and 6 years.

Authors:  Neal R Stewart; Jeffrey P Crabbe; Fiona M McQueen
Journal:  Skeletal Radiol       Date:  2004-10-15       Impact factor: 2.199

6.  Atlanto-odontoid osteoarthritis in rheumatoid arthritis: dynamic CT findings.

Authors:  Ozlem Baysal; Tamer Baysal; Ahmet Sigirci; Yuksel Ersoy; Zuhal Altay
Journal:  Clin Rheumatol       Date:  2004-04-20       Impact factor: 2.980

Review 7.  Can bone loss in rheumatoid arthritis be prevented?

Authors:  M Vis; M Güler-Yüksel; W F Lems
Journal:  Osteoporos Int       Date:  2013-06-18       Impact factor: 4.507

8.  Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs.

Authors:  Haruko Ideguchi; Shigeru Ohno; Hideaki Hattori; Akiko Senuma; Yoshiaki Ishigatsubo
Journal:  Arthritis Res Ther       Date:  2006-04-28       Impact factor: 5.156

9.  Subtle changes in individual joints result in both positive and negative change scores in a patient: results from a clinical trial in patients with rheumatoid arthritis.

Authors:  C Lukas; R Landewé; S Fatenejad; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2008-11-24       Impact factor: 19.103

10.  Expert agreement confirms that negative changes in hand and foot radiographs are a surrogate for repair in patients with rheumatoid arthritis.

Authors:  Désirée van der Heijde; Robert Landewé; Annelies Boonen; Steve Einstein; Gertraud Herborn; Rolf Rau; Siegfried Wassenberg; Barbara N Weissman; Carl S Winalski; John T Sharp
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.